The Wellness Play Strategy Lessons from Safeway

Steve Burd looked at a 6% drop in Safeway’s quarterly profits and saw an existential threat. He decided the traditional grocery business needed a wellness business strategy to escape razor-thin margins and stagnating growth. This strategic framework involves pivoting a low-margin retail operation into a high-margin healthcare provider by using existing store footprints as clinical hubs. It's a bold move that seeks to capture the massive spend in the preventive health sector.

What is The Wellness Play?

The Wellness Play is a strategic pivot where a non-medical business integrates clinical services to transform its value proposition. In his book Bad Blood, John Carreyrou explores how Safeway CEO Steve Burd attempted this through "Project T-Rex." Burd wanted to move beyond selling calories to selling cures. He envisioned a future where customers got their blood tested while shopping for produce, creating a seamless health ecosystem. This concept matters because it reflects the growing trend of retail healthcare where convenience is the primary competitive advantage.

Core Components of the Wellness Model

Repurposing Footprints as Clinical Hubs

Safeway’s strategy relied on converting its massive physical network into a decentralized laboratory. The company operated approximately 1,700 stores and planned to remodel more than half of them to include high-end clinics. These spaces featured granite countertops and flat-screen TVs to look more like spas than sterile hospitals. Statistics from the era show Safeway committed $350 million to these renovations before the technology was even proven.

Why Preventive Medicine Demands Technical Truth

Winning in healthcare requires a shift from transactional sales to high-trust clinical diagnostics. The strategy hinges on the promise that early detection through preventive medicine will lower long-term costs for both the consumer and the company. Safeway’s plan aimed to detect chronic illnesses before they became expensive emergencies. However, the pivot failed because the underlying technology provided by Theranos wasn't just flawed—it was non-existent. Without accurate data, the wellness value proposition collapses into a liability.

Avoiding The Outsourcing Trap in Your Wellness Business Strategy

Most traditional businesses lack the internal expertise to build medical technology from scratch. They must find partners, but this creates a dependency that can be fatal if the due diligence is weak. Steve Burd gave Elizabeth Holmes immense latitude, often telling his deputies he would personally "talk to Elizabeth" whenever concerns arose. This lack of oversight is a common failure point in a wellness business strategy. Relying on an external partner's "black box" without independent verification turns a strategic pivot into a blind gamble.

Safeway’s Costly Experiment in Retail Healthcare

Project T-Rex started as a secret war room in Pleasanton, California. Safeway executives built a replica store with a blood-testing lab to test the customer experience. They were so confident in this retail healthcare play that they offered free checkups to their own employees first. The goal was to prove the model internally before a national rollout.

When actual results came in, the dream hit a wall of reality. One senior Safeway executive received a Theranos report indicating he had prostate cancer based on an elevated PSA reading. A follow-up test at a traditional lab showed his levels were perfectly normal. This discrepancy highlighted the danger of entering a complex field like diagnostics without a firm grasp of the technical requirements.

Execute Your Strategic Pivot Carefully

Three Steps to Audit a Strategic Shift

1. Verify the core technology with third-party experts. Never take a partner's word for the efficacy of a product that sits outside your core competency. Steve Burd ignored his own Chief Medical Officer’s warnings because he was charmed by the founder's vision.

2. Run a localized pilot with zero-risk outcomes. Before Safeway renovated 1,700 stores, they should have run an exhaustive, year-long test in a single market with parallel testing. Parallel testing means running the same blood sample through a trusted lab to confirm the new technology's accuracy.

3. Protect the core brand from technical failure. A retail business relies on trust, and a medical error can destroy decades of brand equity. Structure contracts with a clear "kill switch" that allows the company to exit the partnership if technical milestones aren't met on a transparent schedule.

Why Good CEOs Make Bad Bets

Critics argue that Steve Burd’s obsession with wellness caused him to lose focus on the unglamorous basics of the grocery business. While he chased a $250 million annual revenue boost from clinics, his competitors were busy optimizing supply chains. Analysts at Credit Suisse pointed out that stock buybacks were being used to mask the company's underperformance. The strategy was called oversimplified because it assumed retail foot traffic would naturally translate to medical trust. It also ignored the massive regulatory burden associated with the Clinical Laboratory Improvement Amendments (CLIA) and the FDA.

Safeway’s failed pivot proves that a wellness business strategy requires more than just high-end cabinetry and floor space. Real innovation in the health space is built on clinical evidence, not marketing presentations and celebrity board members. If a strategic shift seems to rely more on the charisma of a partner than on hard data, it is likely a distraction from your core business. Audit your current partnerships for technical transparency to ensure your company isn't the next victim of a high-stakes wellness illusion.

Directly ask your technology partners for raw validation data rather than summarized reports.